Preparation of B1-target anticancer drugs-Immunological magnetic adriamycin nanoparticles and its evaluation in vitro

Jin Chang
1996-01-01
Abstract:Adriamycin and anti-human mammary cancer monoclonal antibody (McAb) were conjugated to magnetic iron-dextran nanoparticles by a periodate oxidation-borohydride reduction procedure. The conjugates were separated out by gel filtration chromatography on Sephacryl S-300 and characterized by SEM and laser scattering system. The mean diameter of nanoparticles is 216 nm and the molar ratio of Ab:Dex:Adr in conjugate is 1:5:94. The conjugates prepared by this procedure have high immunological activity evaluated by ELISA and do not flocculate in physiological buffer. The nanoparticles can well bind the cancer cells and kill 80% of them in vitro, showing that the conjugate has significant retention of biological activity of the antibody. A magnetic field is kept on the simulated blood capillaries. The nanoparticles flowing in the capillaries can be 100% retained in the magnetic area and be removed if the magnetic field disappears, showing that they have high magnetic responsibility and superparamagnetism.
What problem does this paper attempt to address?